Literature DB >> 19404565

Effects of high glucose and thiamine on the balance between matrix metalloproteinases and their tissue inhibitors in vascular cells.

Sonia Tarallo1, Elena Beltramo, Elena Berrone, Patrizia Dentelli, Massimo Porta.   

Abstract

Pericyte survival in diabetic retinopathy depends also on interactions with extracellular matrix (ECM) proteins, which are degraded by matrix metalloproteinases (MMP). Elevated glucose influences ECM turnover, through expression of MMP and their tissue inhibitors, TIMP. We reported on reduced pericyte adhesion to high glucose-conditioned ECM and correction by thiamine. We aimed at verifying the effects of thiamine and benfotiamine on MMP-2, MMP-9 and TIMP expression and activity in human vascular cells with high glucose. In HRP, MMP-2 activity, though not expression, increased with high glucose and decreased with thiamine and benfotiamine; TIMP-1 expression increased with high glucose plus thiamine and benfotiamine; MMP-9 was not expressed. In EC, MMP-9 and MMP-2 expression and activity increased with high glucose, but thiamine and benfotiamine had no effects; TIMP-1 expression was unchanged. Neither glucose nor thiamine modified TIMP-2 and TIMP-3 expression. TIMP-1 concentrations did not change in either HRP or EC. High glucose imbalances MMP/TIMP regulation, leading to increased ECM turnover. Thiamine and benfotiamine correct the increase in MMP-2 activity due to high glucose in HRP, while increasing TIMP-1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404565     DOI: 10.1007/s00592-009-0124-5

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  8 in total

Review 1.  Matrix metalloproteinase 14 modulates diabetes and Alzheimer's disease cross-talk: a meta-analysis.

Authors:  Jack Cheng; Hsin-Ping Liu; Cheng-Chun Lee; Mei-Ying Chen; Wei-Yong Lin; Fuu-Jen Tsai
Journal:  Neurol Sci       Date:  2017-11-04       Impact factor: 3.307

2.  The impact of thiamine treatment in the diabetes mellitus.

Authors:  Khanh Vinh Quoc Luong; Lan Thi Hoang Nguyen
Journal:  J Clin Med Res       Date:  2012-05-15

Review 3.  Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.

Authors:  Maha Coucha; Sally L Elshaer; Wael S Eldahshan; Barbara A Mysona; Azza B El-Remessy
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

4.  STAT1-mediated Bim expression promotes the apoptosis of retinal pericytes under high glucose conditions.

Authors:  E S Shin; Q Huang; Z Gurel; T L Palenski; I Zaitoun; C M Sorenson; N Sheibani
Journal:  Cell Death Dis       Date:  2014-01-09       Impact factor: 8.469

5.  The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients.

Authors:  Bastian Lubis; Aznan Lelo; Putri Amelia; Agus Prima
Journal:  Infect Drug Resist       Date:  2022-09-30       Impact factor: 4.177

Review 6.  Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy.

Authors:  Sayon Roy; Dongjoon Kim
Journal:  Prog Retin Eye Res       Date:  2020-09-18       Impact factor: 21.198

Review 7.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

8.  High glucose concentration up-regulates the expression of matrix metalloproteinase-9 and -13 in tendon cells.

Authors:  Wen-Chung Tsai; Fang-Chen Liang; Ju-Wen Cheng; Li-Ping Lin; Shih-Chieh Chang; Hsiang-Hung Chen; Jong-Hwei S Pang
Journal:  BMC Musculoskelet Disord       Date:  2013-08-27       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.